A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosisXavier Montalbán, Àlex Rovira, Jaume Sastre‐Garriga et al.|Multiple Sclerosis Journal|2009Cited by 108